Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114560761B enables green aqueous synthesis of indanone derivatives. Achieve high purity and cost reduction in API intermediate manufacturing with scalable rhodium catalysis.
Novel patent CN118541351A details mild pyrrole synthesis avoiding chiral resolution. Delivers high purity and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN118791432A enables high-purity Rimegepant intermediate synthesis via low-loading catalyst. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105463033A reveals high-yield biocatalytic route for chiral intermediate. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114058652B reveals enzyme-catalyzed route for Nicardipine intermediate. Achieves high purity and yield while reducing environmental waste significantly.
Patent CN103450072A reveals a novel Simmons-Smith route for R-proline derivatives. Achieve high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Advanced solid-phase synthesis of Bivalirudin using tetraglycine fragments ensures superior purity and supply chain reliability for global pharmaceutical partners.
Patent CN112898205A details a green benzimidazole synthesis using CO2 and a mesoporous polymer catalyst, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114075557B reveals enzymatic synthesis for high-purity Larotrectinib intermediate. Achieve cost reduction and scalable supply chain reliability.
Novel chemical synthesis route for cholic acid intermediate A5 eliminates animal extraction risks. Offers scalable, high-purity pharmaceutical intermediates for global supply chains.
Patent CN104788529B details a novel 4-AD based synthesis route offering superior yield and environmental compliance for scalable steroid intermediate manufacturing.
Patent CN110698379A details a novel levetiracetam preparation method enhancing purity and yield. This report analyzes supply chain advantages and cost reduction in API manufacturing for global procurement teams.
Novel patent CN104558086B details high-yield 6-ECDCA synthesis offering supply chain stability and cost reduction in API manufacturing for global partners.
Patent CN114835605B reveals safer benzophenone hydrazone synthesis. Enhances purity and supply chain stability for global pharmaceutical intermediates manufacturing.
Patent CN1126467A reveals scalable palladium-catalyzed vinyl substitution for high-purity pyridine intermediates, offering cost reduction in API manufacturing.
High-purity scutellarin aglycone preparation via acid hydrolysis. Optimized yield and purity for pharmaceutical supply chains. Reducing lead time for high-purity pharmaceutical intermediates.
Novel patent CN103787998B details cost-effective p-SCN-NODA production. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN102465157B details enzymatic synthesis of pregabalin intermediate offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN114437166A reveals a continuous flow synthesis for hydrocortisone intermediates, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturers.
Novel ionic liquid method enhances Edoxaban Tosylate purity and yield. Offers significant cost reduction in API manufacturing and supply chain reliability for global buyers.